Guidance for Industry: Institutional Review Board Review of Stand-Alone Health Insurance Portability and Accountability Act Authorizations; Availability
Federal Register 2003 November 7; 68(216): 63110-63111 [Online] Available: http://frwebgate.access.gpo.gov/cgi- bin/multidb.cgi [6 October 2004]
Showing items related by title, author, creator and subject.
Guidance for Industry. IRB Review of Stand-Alone HIPAA Authorizations Under FDA Regulations: Final Guidance Unknown author (United States. Food and Drug Administration [FDA]. Office of the Commissioner, 2003-10-21)
Draft Guidance for Industry on Using a Centralized Institutional Review Boards Process in Multicenter Clinical Trials; Availability Unknown author (United States. Food and Drug Administration, 2005-03-28)
Confidentiality of Individually-Identifiable Health Information. Recommendations of the Secretary of Health and Human Services, Pursuant to Section 264 of the Health Insurance Portability and Accountability Act of 1996. Submitted To: The Committee on Labor and Human Resources and the Committee on Finance of the Senate; the Committee on Commerce and the Committee on Ways and Means of the House of Representatives Unknown author (United States. Department of Health & Human Services, 1997-09-11)